Cjm Wealth Advisers, Ltd. Pfizer Inc Transaction History

Cjm Wealth Advisers, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 15, 2023	SELL	$36.12 - $41.79 $251,936 - $291,485	-6,975 Closed	0 $0
Q1 2023 Sep 15, 2023	SELL	$39.39 - $51.28 $9,532 - $12,409	-242 Reduced 3.35%	6,975 $285 Million
Q4 2022 Sep 15, 2023	BUY	$41.75 - $54.5 $208 - $272	5 Added 0.07%	7,217 $370 Million
Q3 2022 Sep 15, 2023	SELL	$43.76 - $53.42 $3,369 - $4,113	-77 Reduced 1.06%	7,212 $316 Million
Q2 2022 Sep 15, 2023	BUY	$46.53 - $55.17 $4,094 - $4,854	88 Added 1.22%	7,289 $382 Million

Q1 2022 Sep 15, 2023	BUY	$45.75 - $56.69 $320 - $396	7 Added 0.1%	7,201 $373 Million
Q4 2021 Sep 15, 2023	BUY	$41.32 - $61.25 $297,256 - $440,632	7,194 New	7,194 $425 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cjm Wealth Advisers, Ltd., based on Form 13F filings with the SEC.

Stay updated on Cjm Wealth Advisers, Ltd. with notifications on news.